Company profile
Bio Green Med Solution, Inc.
NASDAQ: BGMS · Healthcare · Medical - Pharmaceuticals
PublicHQ Kuala Lumpur, CIK 0001130166Reports USD
#902 of 1,422 Healthcare companies by revenuetop-decile growth
EA Score
48DFH 47DQ 54GM —SS 25
v0.1 · 55/100 weight · provisional
↑ revenue growth (YoY), balance-sheet leverage · ↓ listing tenure, Altman-Z
Methodology →Revenue TTM
$1.9M
Rev growth YoY (TTM)
+18510.0%
Net income (FY)
-$3.0M
Employees
12
as of 2026-08-25
Market cap
$4.8M
as of 2026-08-25
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$747.0k$747.0k2025
Net income-$3.0M-$3.0M2025
Operating income-$8.4M-$8.4M2025
Total assets$8.2M$8.2M2025
Liabilities$1.3M$1.3M2025
Equity$6.8M$6.8M2025
Revenue trend
FY2018 – FY2025 · USD
FY18
FY18
FY21
FY21
FY22
FY23
FY24
FY25
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Bio Green Med Solution, Inc.’s revenue?
Bio Green Med Solution, Inc. booked $747.0k in FY2025 revenue, growing 1637% year over year — faster than 97% of Healthcare companies we track, at a -401.3% net margin.
Peers · Healthcare
Tivic Health Systems, Inc.34DParadigm Medical Industries, Inc.——Guided Therapeutics, Inc.42DWearable Health Solutions, Inc.——Dogecoin Cash, Inc.39DAvivagen Inc.——Key facts
CEOSing Ee Wong
SectorHealthcare
IndustryMedical - Pharmaceuticals
HeadquartersKuala Lumpur, null
ExchangeNASDAQ: BGMS
Employees12
IPO date2025-09-12
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.